FACSIMILE: 31 77 355 6640Bond Hedge Transaction • March 2nd, 2015 • Qiagen Nv • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between [ ] (“Dealer”) and Qiagen N.V. (“Counterparty”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.
SUBJECT: Warrant Transaction Reference Number(s): [ ]Warrant Transaction Confirmation • March 2nd, 2015 • Qiagen Nv • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between [ ] (“Dealer”) and Qiagen N. V. (“Counterparty”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.
DEUTSCHE BANK LUXEMBOURG S.A. as Note Registrar, Transfer Agent and Authentication Agent INDENTUREIndenture • March 2nd, 2015 • Qiagen Nv • Biological products, (no disgnostic substances) • New York
INDENTURE dated as of March 19, 2014 among QIAGEN N.V., as issuer (the “Company”), and Deutsche Trustee Company Limited, as Trustee, Deutsche Bank AG, London Branch, as Paying Agent and Conversion Agent, and Deutsche Bank Luxembourg S.A., as Note Registrar and Authentication Agent.
DEUTSCHE BANK LUXEMBOURG S.A. as Note Registrar, Transfer Agent and Authentication Agent INDENTUREIndenture • March 2nd, 2015 • Qiagen Nv • Biological products, (no disgnostic substances) • New York
INDENTURE dated as of March 19, 2014 among QIAGEN N.V., as issuer (the “Company”), and Deutsche Trustee Company Limited, as Trustee, Deutsche Bank AG, London Branch, as Paying Agent and Conversion Agent, and Deutsche Bank Luxembourg S.A., as Note Registrar and Authentication Agent.
PURCHASE AGENT AGREEMENTPurchase Agent Agreement • March 2nd, 2015 • Qiagen Nv • Biological products, (no disgnostic substances) • New York
QIAGEN Euro Finance (Luxembourg) S.A., a Luxembourg corporation (the “Purchaser”) and a wholly-owned subsidiary of QIAGEN N.V., a Dutch corporation (the “Company”), intends to invite holders of its outstanding U.S.$300,000,000 3.25% Senior Convertible Notes due 2026 (ISIN: XS0254367179) (the “2026 Notes”) that are eligible to participate in the Invitation (as defined below) pursuant to the Invitation to Sell Term Sheet (the “Invited Holders”) to sell their 2026 Notes (the “Invitation”).
